A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis.
Phase of Trial: Phase III
Latest Information Update: 16 Jan 2012
At a glance
- Drugs NB 001 (Primary)
- Indications Herpes labialis
- Focus Registrational; Therapeutic Use
- Acronyms SHaRCS
- 16 Jan 2012 Actual patient number (847) added as reported by ClinicalTrials.gov.
- 16 Jan 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
- 16 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.